All Resources

ASPS22: Coordination of Care for Anticoagulated Patients Undergoing Reconstruction After Skin Cancer Resection+

ASPS22: Coordination of Care for Anticoagulated Patients Undergoing Reconstruction After Skin Cancer Resection+

Download PDF


High Priority: Yes; Care Coordination
NQF Number: N/A

Percentage of patients aged 18 and older on prescribed anticoagulation medication who underwent reconstruction after skin cancer resection (in any setting) and preoperative modification* to their anticoagulant(s) regimen, who had documentation of coordinated care** prior to their procedure.

Denominator:

All patients aged 18 and older on prescribed anticoagulation medication who underwent reconstruction after skin cancer resection (in any setting) and preoperative modification* to their anticoagulant(s) regimen.

*Modification is indicated by change, reduction, or discontinuation of the current anticoagulant medication(s)

  • Age > 18 years;
  • AND
  • CPT® for Encounter:
    • 14000, 14001, 14020, 14021, 14040, 14041, 14060, 14061
    • 14301, 14350
    • 15050
    • 15100,15120
    • 15200, 15220, 15240, 15260
    • 15570, 15572, 15574, 15576
    • 40525, 40527
    • 15730, 15731, 15733, 15740, 15760
    • 67971, 67973, 67974, 67975
  • AND
  • ICD-10 Codes for most common skin cancers:
    • C43-C44
    • D03-D04
  • AND
  • Modification* to the anticoagulant(s) regimen

Denominator Exclusions:

None

Denominator Exceptions:

Patient reason exceptions such as patients who choose to stop therapy on their own or by other physician
recommendation, or who do not have a current physician managing their medication.

Numerator:

Patients who had documentation of coordinated care** prior to their procedure.

**Documentation of coordinated care = documentation of discussion with physician currently managing the anticoagulation therapy (such as a cardiologist or primary care physician)

Numerator Exclusions:

None

Measure Classifications:

  • Measure Type: Process
  • National Quality Strategy (NQS) domain: Communication and Care Coordination
  • Meaningful Measure Area: Medication Management
  • Care Setting(s): Ambulatory Care: Clinician Office/Clinic
  • Includes Telehealth: No
  • Calculation: 1st Performance Rate
    • Inverse measure: No
    • Continuous measure: No
    • Proportional measure: Yes
    • Ratio measure: No
    • Risk Adjusted measure: No

© 2021 American Society of Plastic Surgeons. All Rights Reserved.

Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g. use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user, the American Society of Plastic Surgeons (ASPS) and American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF). All Rights Reserved.


Disclaimer:

The Measures are not clinical guidelines, do not establish a standard of medical care, and have not been tested for all potential applications. THE MEASURES AND SPECIFICATIONS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND. Neither the AAO-HNSF nor its members shall be responsible for any use of the Measures. The AAO-HNSF and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.

AAO-HNS COVID-19 InformationLearn More